RE:RE:Check out VERSARTIS INCOne of the things thats been an attraction to me about Prometics value proposition is the diversity of opportunity created by its novel technology platform. I dont invest in one trick pharma ponies like VSAR because of the risk of an outcome like a trial endpoint failure and the catastrophic result their shareholders are experiencing.
Prometic has managed to build an IP pipeline of very diverse opportunity and value across multiple indications and really derisked via consecutive successful safety and efficacy trials. The PPPS platform is going to ne a dependable cash cow. Their small molecule drugs early trial successes in Fibtoric diseases and the unique mechanism of action is only now truly being discovered by industry and the market PL and the BoD have grown this company to the point where the risk of catastrophic failure is all but gone, and thats extremely rare in this business! Particularly when you conside they have still managed to hang on to the blockbuster potential. I think the recent Cannacord and Scotia analyst updates have it right
This is exactly why smart /big money is beginning to own this story, and that will only accelerate as PLI matures into commrcialization stage , when they will be able to fund further IP and drug development organically. Cant say that for many small caps in this sector